Share ownership Changchun BCHT Biotechnology Co.

688276

CNE100005XY6

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 2026-01-20			5-day change	1st Jan Change
19.85 ^CNY	-0.30%		-2.89%	+5.25%

11-13	BCHT Biotechnology Gets Nod to Trial Vaccines Against Pertussis, Diphtheria, Tetanus	MT
25-10-30	Changchun BCHT Biotechnology Co. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI

Share class: Changchun BCHT Biotechnology Co.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	413,657,598	92,880,789 ( 22.45 %)	0	22.45 %

Major shareholders: Changchun BCHT Biotechnology Co.

Name	Equities	%	Valuation
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. 41.46 %	171,488,182	41.46 %	463 M ¥
Wei Kong 25.25 %	104,448,497	25.25 %	282 M ¥
Xue Ning Wei 5 %	20,682,880	5 %	56 M ¥
Shang Shu Hu 1.45 %	6,000,000	1.45 %	16 M ¥
Xiao Hui Chen 1.326 %	5,485,733	1.326 %	15 M ¥
Yijun Shi 0.9292 %	3,843,759	0.9292 %	10 M ¥
Hong Wang 0.7915 %	3,274,096	0.7915 %	9 M ¥
City of Changchun 0.6999 %	2,895,124	0.6999 %	8 M ¥
China Asset Management Co., Ltd. 0.4084 %	1,689,540	0.4084 %	5 M ¥
China Southern Asset Management Co., Ltd. 0.3966 %	1,640,675	0.3966 %	4 M ¥
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Changchun High-Tech Industry (Group) Co., Ltd.	41.46%
Individuals	35.75%
Institutional	2.03%
Governments	0.7%
Unknown	20.07%

Based on 1000 largest holdings

Geographical origin of shareholders

China	44.18%
Individuals	35.75%

Based on 1000 largest holdings

Changchun BCHT Biotechnology Co is a China-based innovative biomedical company mainly dedicated to the prevention and treatment of infectious diseases. The Company is mainly engaged in the research and development, production and sales of human vaccines. The Company has three approved vaccine products: varicella vaccine, rabies vaccine and freeze-dried nasal spray flu vaccine. The Company also has other vaccines under development and fully human monoclonal antibody under development for the prevention and control of infectious diseases. The Company mainly conducts business within the domestic market.

Employees

1,274

Sector

Pharmaceuticals

Calendar

03-11 - Q4 2025 Earnings Release

More about the company